Walgreens, CVS Pull Zantac Off Shelves Over Carcinogen Concerns

The video discusses concerns over Zantac containing a probable carcinogen, leading CBS and Walgreens to suspend its sales. The FDA is investigating the impurity MDMA in ranitidine products. While no recall has been issued, consumers are advised to consult doctors if they wish to stop using the drug. Refunds are available for returned products.

What new insight or understanding did you gain from this video?